IMUC (OTC)
EOM PHARMACEUTICAL HLDNGS
$0.200000
+0.068400 (+51.98%)
Prev close: $0.131600
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Anthony J. Gringeri, PhD
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $1.30M
- Employees
- —
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2017 (Q3)
|
$-4.00 | $-6.22 | +2.2220 | +35.71% |
|
Dec 2016 (Q4)
|
$-13.60 | $-12.24 | -1.3600 | -11.11% |
|
Sep 2016 (Q3)
|
$-16.00 | $-16.32 | +0.3200 | +1.96% |
|
Jun 2016 (Q2)
|
$-24.00 | $-28.56 | +4.5600 | +15.97% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $5.66M |
| Research and Development | $2.44M |
| Other Operating Expenses | $3.23M |
| Operating Income/Loss | -$5.66M |
| Income/Loss From Continuing Operations After Tax | -$5.66M |
| Income/Loss From Continuing Operations Before Tax | -$5.66M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Expense, Operating | $0.00 |
| Net Income/Loss | -$5.66M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$5.66M |
| Net Income/Loss Available To Common Stockholders, Basic | -$9.03M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $3.37M |
| Preferred Stock Dividends And Other Adjustments | $3.37M |
| Assets | $3.83M |
| Current Assets | $3.83M |
| Noncurrent Assets | $356.00 |
| Fixed Assets | $356.00 |
| Liabilities | $401.94K |
| Current Liabilities | $401.94K |
| Accounts Payable | $84.26K |
| Wages | $156.23K |
| Other Current Liabilities | $161.46K |
| Noncurrent Liabilities | $0.00 |
| Equity | $3.43M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.43M |
| Liabilities And Equity | $3.83M |
| Net Cash Flow From Operating Activities | -$10.93M |
| Net Cash Flow From Operating Activities, Continuing | -$10.93M |
| Net Cash Flow From Financing Activities | $11.96M |
| Net Cash Flow | $1.04M |
| Net Cash Flow, Continuing | $1.04M |
| Comprehensive Income/Loss | -$5.66M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$5.66M |
| Other Comprehensive Income/Loss | $0.00 |